EU throws shade as UK approves COVID-19 vaccine after 10-day evaluation

A man with a face mask, goggles, and tousled hair examines a small vial.

Enlarge / UK Prime Minister Boris Johnson poses for {a photograph} with a vial of the AstraZeneca/Oxford College COVID-19 candidate vaccine, generally known as AZD1222, at Wockhardt’s pharmaceutical manufacturing facility on November 30, 2020 in Wrexham, Wales. (credit score: Getty | WPA Pool)

Regulators and well being officers in the UK are waving the Union Jack right this moment, celebrating being the primary nation to approve the COVID-19 vaccine developed by US-based pharmaceutical large Pfizer and German biotech agency BioNTech.

The frontrunner vaccine is below evaluation in regulatory businesses around the globe, together with the US Meals and Drug Administration and the European Union’s European Medicines Company. However the UK was the primary to offer the vaccine the green-light after a remarkably quick 10-day evaluation. In non-pandemic occasions, such opinions usually take months.

“The UK was the primary nation to signal a cope with Pfizer/BioNTech—now we would be the first to deploy their vaccine,” UK Enterprise Secretary Alok Sharma wrote in a tweet. “In years to return, we are going to bear in mind this second because the day the UK led humanity’s cost towards this illness.”

Learn 11 remaining paragraphs | Feedback

Related Posts

Leave a Reply

Your email address will not be published.